Development and Validation of Artificial Neural Networks for Survival Prediction Model for Patients with Spontaneous Hepatocellular Carcinoma Rupture After Transcatheter Arterial Embolization

References

• YangJD, HainautP, GoresGJ, AmadouA, PlymothA, RobertsLR. A global view of hepatocellular carcinoma: trends, risk, prevention and management. Nat Rev Gastroenterol Hepatol. 2019;16(10):589–604. doi:10.1038/s41575-019-0186-y31439937
   PubMed Web of Science ®Google Scholar
• BoschFX, RibesJ, DíazM, ClériesR. Primary liver cancer: worldwide incidence and trends. Gastroenterology. 2004;127(Suppl 5):S5–S16. doi:10.1053/j.gastro.2004.09.01115508102
   PubMed Web of Science ®Google Scholar
• LiuZ, SuoC, MaoX, et al. Global incidence trends in primary liver cancer by age at diagnosis, sex, region, and etiology, 1990–2017. Cancer. 2020;126(10):2267–2278. doi:10.1002/cncr.3278932201944
   PubMed Web of Science ®Google Scholar
• DasguptaP, HenshawC, YouldenDR, ClarkPJ, AitkenJF, BaadePD. Global trends in incidence rates of primary adult liver cancers: a systematic review and meta-analysis. Front Oncol. 2020;10:171. doi:10.3389/fonc.2020.0017132185125
   PubMed Web of Science ®Google Scholar
• ZhuRX, SetoWK, LaiCL, YuenMF. Epidemiology of hepatocellular carcinoma in the Asia-Pacific region. Gut Liver. 2016;10(3):332–339. doi:10.5009/gnl1525727114433
   PubMed Web of Science ®Google Scholar
• LinHM, LeiLM, ZhuJ, LiGL, MinJ. Risk factor analysis of perioperative mortality after ruptured bleeding in hepatocellular carcinoma. World J Gastroenterol. 2014;20(40):14921–14926. doi:10.3748/wjg.v20.i40.1492125356052
   PubMed Web of Science ®Google Scholar
• KirikoshiH, SaitoS, YonedaM, et al. Outcomes and factors influencing survival in cirrhotic cases with spontaneous rupture of hepatocellular carcinoma: a multicenter study. BMC Gastroenterol. 2009;9(1):29. doi:10.1186/1471-230x-9-2919405938
   PubMed Web of Science ®Google Scholar
• DewarGA, GriffinSM, KuKW, LauWY, LiAK. Management of bleeding liver tumours in Hong Kong. Br J Surg. 1991;78(4):463–466. doi:10.1002/bjs.18007804241851653
   PubMed Web of Science ®Google Scholar
• LaiEC, LauWY. Spontaneous rupture of hepatocellular carcinoma: a systematic review. Arch Surg. 2006;141(2):191–198. doi:10.1001/archsurg.141.2.19116490898
   PubMedGoogle Scholar
• MinHJ, LeeOJ, KangDY, et al. [The clinical study on spontaneously ruptured hepatocellular carcinoma]. Korean J Gastroenterol. 2004;44(3):160–167. Korean.15385725
   PubMedGoogle Scholar
• RousselE, BubenheimM, Le TreutY-P, et al. Peritoneal carcinomatosis risk and long-term survival following hepatectomy for spontaneous hepatocellular carcinoma rupture: results of a multicenter French study (French-AFC). Ann Surg Oncol. 2020;27(9):3383–3392. doi:10.1245/s10434-020-08442-532285281
   PubMed Web of Science ®Google Scholar
• KwonJH, SongGW, HwangS. et al. Surgical outcomes of spontaneously ruptured hepatocellular carcinoma. World J Gastrointest Surg. 2020;25(4):941–953. doi:10.1007/s11605-020-04555-0
   Web of Science ®Google Scholar
• YoshidaH, MamadaY, TaniaiN, UchidaE. Spontaneous ruptured hepatocellular carcinoma. Hepatol Res. 2016;46(1):13–21. doi:10.1111/hepr.1249825631290
   PubMed Web of Science ®Google Scholar
• YehCN, LeeWC, JengLB, ChenMF, YuMC. Spontaneous tumour rupture and prognosis in patients with hepatocellular carcinoma. Br J Surg. 2002;89(9):1125–1129. doi:10.1046/j.1365-2168.2002.02188.x12190677
   PubMed Web of Science ®Google Scholar
• YangT, SunYF, ZhangJ, et al. Partial hepatectomy for ruptured hepatocellular carcinoma. Br J Surg. 2013;100(8):1071–1079. doi:10.1002/bjs.916723754648
   PubMed Web of Science ®Google Scholar
• XiangX, LauW-Y, WuZ-Y, et al. Transarterial chemoembolization versus best supportive care for patients with hepatocellular carcinoma with portal vein tumor thrombus: a multicenter study. Eur J Surg Oncol. 2019;45(8):1460–1467. doi:10.1016/j.ejso.2019.03.04231005471
   PubMed Web of Science ®Google Scholar
• LeY, ShenJ-X, ZhangY-F, et al. Transarterial chemoembolization related to good survival for selected patients with advanced hepatocellular carcinoma. J Cancer. 2019;10(3):665–671. doi:10.7150/jca.2852830719164
   PubMed Web of Science ®Google Scholar
• FanWZ, ZhangYQ, YaoW, et al. Is emergency transcatheter hepatic arterial embolization suitable for spontaneously ruptured hepatocellular carcinoma in Child-Pugh C cirrhosis?J Vasc Interv Radiol. 2018;29(3):404–412.e3. doi:10.1016/j.jvir.2017.09.02229249595
   PubMed Web of Science ®Google Scholar
• ZouJ, LiC, ChenY, et al. Retrospective analysis of transcatheter arterial chemoembolization treatment for spontaneously ruptured hepatocellular carcinoma. Oncol Lett. 2019;18(6):6423–6430. doi:10.3892/ol.2019.1103731807165
   PubMed Web of Science ®Google Scholar
• HuX, CammannH, MeyerHA, MillerK, JungK, StephanC. Artificial neural networks and prostate cancer–tools for diagnosis and management. Nat Rev Urol. 2013;10(3):174–182. doi:10.1038/nrurol.2013.923399728
   PubMed Web of Science ®Google Scholar
• MarreroJA, KulikLM, SirlinCB, et al. Diagnosis, staging, and management of hepatocellular carcinoma: 2018 practice guidance by the American Association for the study of liver diseases. Hepatology. 2018;68(2):723–750. doi:10.1002/hep.2991329624699
   PubMed Web of Science ®Google Scholar
• OkudaK, ObataH, NakajimaY, OhtsukiT, OkazakiN, OhnishiK. Prognosis of primary hepatocellular carcinoma. Hepatology. 1984;4(1 Suppl):3s–6s. doi:10.1002/hep.18400407036319264
   PubMed Web of Science ®Google Scholar
• LlovetJM, BrúC, BruixJ. Prognosis of hepatocellular carcinoma: the BCLC staging classification. Semin Liver Dis. 1999;19(3):329–338. doi:10.1055/s-2007-100712210518312
   PubMed Web of Science ®Google Scholar
• Cancer of the Liver Italian Program (CLIP) Investigators. A new prognostic system for hepatocellular carcinoma: a retrospective study of 435 patients: the Cancer of the Liver Italian Program (CLIP) investigators. Hepatology. 1998;28(3):751–755. doi:10.1002/hep.5102803229731568
   PubMed Web of Science ®Google Scholar
• LeungTW, TangAMY, ZeeB, et al. Construction of the Chinese university prognostic index for hepatocellular carcinoma and comparison with the TNM staging system, the Okuda staging system, and the cancer of the liver Italian program staging system: a study based on 926 patients. Cancer. 2002;94(6):1760–1769. doi:10.1002/cncr.1038411920539
   PubMed Web of Science ®Google Scholar
• KudoM, ChungH, OsakiY. Prognostic staging system for hepatocellular carcinoma (CLIP score): its value and limitations, and a proposal for a new staging system, the Japan Integrated Staging score (JIS score). J Gastroenterol. 2003;38(3):207–215. doi:10.1007/s00535030003812673442
   PubMed Web of Science ®Google Scholar
• ZhangBH, WangXH, YueHY, LingCQ. A new staging system is more discriminant than conventional staging systems for unresectable hepatocellular carcinoma. J Cancer Res Clin Oncol. 2010;136(6):821–827. doi:10.1007/s00432-009-0722-119916022
   PubMed Web of Science ®Google Scholar
• ZhouJ, SunH-C, WangZ, et al. Guidelines for diagnosis and treatment of primary liver cancer in China (2017 Edition). Liver Cancer. 2018;7(3):235–260. doi:10.1159/00048803530319983
   PubMed Web of Science ®Google Scholar
• JohnsonPJ, BerhaneS, KagebayashiC, et al. Assessment of liver function in patients with hepatocellular carcinoma: a new evidence-based approach-the ALBI grade. J Clin Oncol. 2015;33(6):550–558. doi:10.1200/jco.2014.57.915125512453
   PubMed Web of Science ®Google Scholar
• RahbariNN, GardenOJ, PadburyR, et al. Posthepatectomy liver failure: a definition and grading by the International Study Group of Liver Surgery (ISGLS). Surgery. 2011;149(5):713–724. doi:10.1016/j.surg.2010.10.00121236455
   PubMed Web of Science ®Google Scholar
• VickersAJ, ElkinEB. Decision curve analysis: a novel method for evaluating prediction models. Med Decis Making. 2006;26(6):565–574. doi:10.1177/0272989x0629536117099194
   PubMed Web of Science ®Google Scholar
• AokiT, KokudoN, MatsuyamaY, et al. Prognostic impact of spontaneous tumor rupture in patients with hepatocellular carcinoma: an analysis of 1160 cases from a nationwide survey. Ann Surg. 2014;259(3):532–542. doi:10.1097/SLA.0b013e31828846de23478524
   PubMed Web of Science ®Google Scholar
• FornerA, LlovetJM, BruixJ. Hepatocellular carcinoma. Lancet. 2012;379(9822):1245–1255. doi:10.1016/s0140-6736(11)61347-022353262
   PubMed Web of Science ®Google Scholar
• ZhouC, ZuQ-Q, LiuX-L, et al. Treatment strategies and prognosis for initially unresectable ruptured hepatocellular carcinoma: a single-center experience in 94 patients. Diagn Interv Radiol. 2020;26(3):223–229. doi:10.5152/dir.2019.1904932209506
   PubMed Web of Science ®Google Scholar
• WangB, LuY, ZhangXF, YúL, PanCE, WuZ. Management of spontaneous rupture of hepatocellular carcinoma. ANZ J Surg. 2008;78(6):501–503. doi:10.1111/j.1445-2197.2008.04543.x18522574
   PubMed Web of Science ®Google Scholar
• LiuCL, FanS-T, LoC-M, et al. Management of spontaneous rupture of hepatocellular carcinoma: single-center experience. J Clin Oncol. 2001;19(17):3725–3732. doi:10.1200/jco.2001.19.17.372511533094
   PubMed Web of Science ®Google Scholar
• RaoulJL, FornerA, BolondiL, CheungTT, KloecknerR, de BaereT. Updated use of TACE for hepatocellular carcinoma treatment: how and when to use it based on clinical evidence. Cancer Treat Rev. 2019;72:28–36. doi:10.1016/j.ctrv.2018.11.00230447470
   PubMed Web of Science ®Google Scholar
• Huitzil-MelendezFD, CapanuM, O’ReillyEM, et al. Advanced hepatocellular carcinoma: which staging systems best predict prognosis?J Clin Oncol. 2010;28(17):2889–2895. doi:10.1200/jco.2009.25.989520458042
   PubMed Web of Science ®Google Scholar
• LiaoR, LiDW, DuCY, LiM. Combined preoperative ALBI and FIB-4 is associated with recurrence of hepatocellular carcinoma after curative hepatectomy. World J Gastrointest Surg. 2018;22(10):1679–1687. doi:10.1007/s11605-018-3810-1
   Web of Science ®Google Scholar
• YeL, LiangR, ZhangJ, et al. Postoperative albumin-bilirubin grade and albumin-bilirubin change predict the outcomes of hepatocellular carcinoma after hepatectomy. Ann Transl Med. 2019;7(16):367. doi:10.21037/atm.2019.06.0131555681
   PubMed Web of Science ®Google Scholar
• BattulaN, MadanurM, PriestO, et al. Spontaneous rupture of hepatocellular carcinoma: a Western experience. Am J Surg. 2009;197(2):164–167. doi:10.1016/j.amjsurg.2007.10.01618926518
   PubMed Web of Science ®Google Scholar
• YamagataM, MaedaT, IkedaY, ShirabeK, NishizakiT, KoyanagiN. Surgical results of spontaneously ruptured hepatocellular carcinoma. Hepato-gastroenterology. 1995;42(5):461–474.8751197
   PubMedGoogle Scholar
• ZhuK, ChenJ, LaiL, et al. Hepatocellular carcinoma with portal vein tumor thrombus: treatment with transarterial chemoembolization combined with sorafenib–a retrospective controlled study. Radiology. 2014;272(1):284–293. doi:10.1148/radiol.1413194624708192
   PubMed Web of Science ®Google Scholar
• MartinoMM, BriquezPS, RangaA, LutolfMP, HubbellJA. Heparin-binding domain of fibrin(ogen) binds growth factors and promotes tissue repair when incorporated within a synthetic matrix. Proc Natl Acad Sci USA. 2013;110(12):4563–4568. doi:10.1073/pnas.122160211023487783
   PubMed Web of Science ®Google Scholar
• RuhlCE, EverhartJE. Elevated serum alanine aminotransferase and gamma-glutamyltransferase and mortality in the United States population. Gastroenterology. 2009;136(2):477–85.e11. doi:10.1053/j.gastro.2008.10.05219100265
   PubMed Web of Science ®Google Scholar
• KunutsorSK. Gamma-glutamyltransferase-friend or foe within?Liver Int. 2016;36(12):1723–1734. doi:10.1111/liv.1322127512925
   PubMed Web of Science ®Google Scholar
• CortiA, DuarteTL, GiommarelliC, et al. Membrane gamma-glutamyl transferase activity promotes iron-dependent oxidative DNA damage in melanoma cells. Mutat Res. 2009;669(1–2):112–121. doi:10.1016/j.mrfmmm.2009.05.01019505483
   PubMed Web of Science ®Google Scholar